News
For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...
GlobalData analysis predicts the global GLP-1RA market will reach $168bn by 2033, with Novo Nordisk and Eli Lilly to dominate ...
IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But Weight ...
Cosmetic Dermatology & MediSpa of NJ, a leading cosmetic dermatology center in New Jersey (with locations in Englewood, Wayne, and Newark), proudly announces a notable increase in demand for BodyTite, ...
9h
The Print on MSNMounjaro vs Wegovy: Guess which obesity drug outperformed the other by a mile in head-to-head trialBoth medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...
Meghan Trainor changed a certain lyric in "All About That Bass" during a May 10 performance in Huntington Beach, Calif.
WGN’s Dina Bair has the latest on new medical information, including: Study: Mounjaro helped people achieve more weight loss ...
15h
Study Finds on MSNWeight Loss Showdown: Mounjaro (Tirzepatide) Trounces Wegovy in Head-to-Head TrialIn a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...
The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...
The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results